| P2093 | author name string | Jinlong Hu | |
| | Yuelai Zhou | |
| P2860 | cites work | Dying two deaths - programmed cell death regulation in development and disease | Q28075376 |
| | Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein | Q28538867 |
| | The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest | Q34612455 |
| | Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa | Q37496490 |
| | Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy | Q37575208 |
| | Apoptosis and oncogenesis: give and take in the BCL-2 family | Q37828794 |
| | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 |
| | Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo | Q39147346 |
| | Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. | Q40162826 |
| | The long-term treatment outcomes of adult osteosarcoma | Q40191335 |
| | Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms | Q40282699 |
| | Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. | Q40555412 |
| | Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression. | Q40813050 |
| | miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22. | Q42318103 |
| | Evodiamine, a constituent of Evodiae Fructus, induces anti‐proliferating effects in tumor cells | Q44412165 |
| | Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo | Q45261079 |
| | Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics | Q47169512 |
| | Current and future therapeutic approaches for osteosarcoma. | Q47360357 |
| | Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio | Q47866047 |
| | Primary osteosarcoma of frontal bone: A case report and review of literature | Q49486116 |
| | Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21. | Q50161308 |
| | The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer. | Q54535188 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 5874-5880 | |
| P577 | publication date | 2018-08-23 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway | |
| P478 | volume | 24 | |